13:53:10 EDT Sat 11 Jul 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:STAA - STAAR SURGICAL CO - https://www.staar.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
STAA - Q0.124.81·40.541.827.76-0.21-0.8368.49,6798,10227.92  28.175  27.26535.87  15.58516:23:47May 2115 min RT 2¢

Recent Trades - Last 10 of 8102
Time ETExPriceChangeVolume
16:23:47Q27.12-0.851
16:10:04Q27.76-0.211
16:10:04Q27.76-0.211
16:10:04Q27.76-0.211
16:10:04Q27.76-0.211
16:04:49Q27.76-0.211
16:04:47Q27.76-0.211
16:04:33Q27.76-0.211
16:04:33Q27.76-0.211
16:04:27Q27.76-0.211

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-21 16:01U:STAANews ReleaseSTAAR Surgical Announces Participation in Upcoming Investor Conferences
2026-05-13 16:01U:STAANews ReleaseSTAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
2026-05-04 16:01U:STAANews ReleaseSTAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
2026-04-08 16:01U:STAANews ReleaseSTAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
2026-03-03 16:02U:STAANews ReleaseSTAAR Surgical Issues Shareholder Letter
2026-03-03 16:01U:STAANews ReleaseSTAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
2026-02-25 16:01U:STAANews ReleaseSTAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
2026-02-23 16:01U:STAANews ReleaseSTAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
2026-02-17 16:01U:STAANews ReleaseFDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
2026-02-02 07:00U:STAANews ReleaseSTAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
2026-01-15 08:30U:STAANews ReleaseSTAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
2026-01-06 09:52U:STAANews ReleaseBroadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
2026-01-06 08:47U:STAANews ReleaseSTAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
2025-12-19 12:59U:STAANews ReleaseBroadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon
2025-12-19 11:45U:STAANews ReleaseAlcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
2025-12-17 16:53U:STAANews ReleaseDefender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
2025-12-17 13:17U:STAANews ReleaseBroadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
2025-12-17 10:55U:STAANews ReleaseSTAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
2025-12-16 13:32U:STAANews ReleaseYunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory
2025-12-16 09:12U:STAANews ReleaseIndependent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction